Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001104659-13-021753
Filing Date
2013-03-18
Accepted
2013-03-18 16:26:16
Documents
17
Period of Report
2012-12-31

Document Format Files

Seq Description Document Type Size
1 10-K a13-1277_110k.htm 10-K 1930356
2 EX-2.1 a13-1277_1ex2d1.htm EX-2.1 718
3 EX-10.3 a13-1277_1ex10d3.htm EX-10.3 102433
4 EX-10.4 a13-1277_1ex10d4.htm EX-10.4 109249
5 EX-10.7 a13-1277_1ex10d7.htm EX-10.7 430433
6 EX-23 a13-1277_1ex23.htm EX-23 3807
7 EX-31.1 a13-1277_1ex31d1.htm EX-31.1 12080
8 EX-31.2 a13-1277_1ex31d2.htm EX-31.2 12161
9 EX-32.1 a13-1277_1ex32d1.htm EX-32.1 6223
10 EX-32.2 a13-1277_1ex32d2.htm EX-32.2 6236
17 GRAPHIC g12771ba05i001.jpg GRAPHIC 48128
  Complete submission text file 0001104659-13-021753.txt   11700894

Data Files

Seq Description Document Type Size
11 XBRL INSTANCE DOCUMENT sgyp-20121231.xml EX-101.INS 1568262
12 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT sgyp-20121231.xsd EX-101.SCH 87405
13 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT sgyp-20121231_cal.xml EX-101.CAL 75336
14 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT sgyp-20121231_def.xml EX-101.DEF 376412
15 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT sgyp-20121231_lab.xml EX-101.LAB 1154583
16 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT sgyp-20121231_pre.xml EX-101.PRE 551573
Mailing Address 420 LEXINGTON AVENUE SUITE 1609 NEW YORK NY 10170
Business Address 420 LEXINGTON AVENUE SUITE 1609 NEW YORK NY 10170 212-297-0010
SYNERGY PHARMACEUTICALS, INC. (Filer) CIK: 0001347613 (see all company filings)

EIN.: 330505269 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-35268 | Film No.: 13697975
SIC: 2834 Pharmaceutical Preparations